Drug Trial Radar · NCT01511978
Effectiveness of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Last checked: Nov 20, 2026Latest source record: Jul 11, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
Jan 2012
Primary completion
Feb 2014
Study completion Jul 2015
Sponsor
- Lead sponsor
- Jacobus PharmaceuticalIndustry
- Sponsor type
- Industry
- First posted
- Jan 19, 2012
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Hypothesis: 3,4-Diaminopyridine base (3,4-DAP) improves Lambert-Eaton Myasthenic Syndrome (LEMS)-related weakness.
Conditions
- Lambert-Eaton Myasthenic Syndrome
- Eaton-Lambert Myasthenic Syndrome
Interventions
Continuous 3,4-DAPDrug
Subjects were maintained on their usual personal dose and schedule of 3,4-DAP base
Taper 3,4-DAP to PlaceboDrug
Subjects were tapered over 3 days from their usual regimen of 3,4-DAP base to placebo with up to an additional 16 hours of placebo before resuming their usual pre-study regimen of 3,4-DAP base
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With 30% or More Deterioration in Triple Timed Up & Go (3TUG) Test, Compared to Time-matched BaselineTime frame: Baseline period (days 0, 1, 2); Randomized treatment period (starting with last dose of day 2, and days 3, 4, 5, and ending with first dose on day 6 when pre-randomization regimen was resumed, or rescue, if indicated sooner)
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
University of California at Davis
Sacramento, California
Indiana University
Indianapolis, Indiana
Duke University
Durham, North Carolina
Oregon Health & Science University
Portland, Oregon
Vanderbilt University Medical Center
Nashville, Tennessee
Baylor College of Medicine
Houston, Texas
University of Utah
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.